Viking Therapeutics VKTX
NASDAQ VKTX
$24.40 -1.43 (-5.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Cash & Current Investments (2014 - 2026)

Updated

Viking Therapeutics' Cash & Current Investments was $501.66 million in Q2 2026, down 37.9% from $807.72 million a year earlier and down 16.8% from the prior quarter.

Analysis

Viking Therapeutics (VKTX) Cash & Current Investments (2014 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Viking Therapeutics came in at $705.74 million, down 21.8% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $902.61 million in FY2024 (+149.3%), $362.08 million in FY2023 (+132.9%), $155.49 million in FY2022 (-23.1%) and $202.1 million in FY2021 (-18.6%).
  • The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q4 2023.
  • Compared with a year earlier, Cash & Current Investments has declined for six straight quarters, with growth averaging 19.8% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q1 2024 (growth of 609.8%); the worst was Q2 2026 (a decline of 37.9%).
  • Per Business Quant data, VKTX's Cash & Current Investments in the three quarters before Q2 2026 was $602.96 million (Q1 2026), $705.74 million (Q4 2025) and $714.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Viking Therapeutics 2.85 Bn 321.40 Mn - 501.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 501.66 Mn
Mar 31, 2026 602.96 Mn
Dec 31, 2025 705.74 Mn
Sep 30, 2025 714.57 Mn
Jun 30, 2025 807.72 Mn
Mar 31, 2025 851.86 Mn
Dec 31, 2024 902.61 Mn
Sep 30, 2024 930.44 Mn
Jun 30, 2024 942.26 Mn
Mar 31, 2024 962.98 Mn
Dec 31, 2023 362.08 Mn
Sep 30, 2023 376.24 Mn
Jun 30, 2023 392.92 Mn
Mar 31, 2023 135.66 Mn
Dec 31, 2022 155.49 Mn
Sep 30, 2022 155.02 Mn
Jun 30, 2022 168.92 Mn
Mar 31, 2022 184.90 Mn
Dec 31, 2021 202.10 Mn
Sep 30, 2021 216.14 Mn
API Access

Viking Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VKTX&period=max&api_key=YOUR_API_KEY